US20020055620A1 - Reduction inhibitory agent for active oxygen eliminating activity - Google Patents

Reduction inhibitory agent for active oxygen eliminating activity Download PDF

Info

Publication number
US20020055620A1
US20020055620A1 US09/984,392 US98439201A US2002055620A1 US 20020055620 A1 US20020055620 A1 US 20020055620A1 US 98439201 A US98439201 A US 98439201A US 2002055620 A1 US2002055620 A1 US 2002055620A1
Authority
US
United States
Prior art keywords
composition
plant
active
trehalose
oxygen eliminating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/984,392
Other languages
English (en)
Inventor
Hajime Aga
Takashi Shibuya
Shigeharu Fukuda
Toshio Miyake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Priority to US09/984,392 priority Critical patent/US20020055620A1/en
Publication of US20020055620A1 publication Critical patent/US20020055620A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/719—Pullulans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282—Artemisia, e.g. wormwood or sagebrush
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/287—Chrysanthemum, e.g. daisy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A61K36/315—Isatis, e.g. Dyer's woad
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/482—Cassia, e.g. golden shower tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/51—Gentianaceae (Gentian family)
    • A61K36/515—Gentiana
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/52—Juglandaceae (Walnut family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/535—Perilla (beefsteak plant)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/894—Dioscoreaceae (Yam family)
    • A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8994—Coix (Job's tears)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8998—Hordeum (barley)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins

Definitions

  • the present invention relates to an agent which inhibits reduction of active oxygen-eliminating activity, uses of the same, and a method for inhibiting reduction of active oxygen eliminating activity. More particularly, the present invention relates to an agent for inhibiting reduction of active oxygen eliminating activity which comprises trehalose as an active ingredient, uses of the same as compositions which can be obtained by incorporating the inhibitory agent into edible plant substances, and/or plant antioxidants, and a method for inhibiting the reduction of active oxygen eliminating activity of plant substances.
  • these incurable diseases may be related to active oxygen molecules such as superoxide, which is an oxygen molecule having an unpaired electron and relatively high reactivity, and derivatives thereof, including hydroxyradical and hydrogen peroxide. It is believed that these molecules oxidize intracellular target molecules such as membrane lipids, proteins, and DNAs to induce oxygen-related defects and cause aging of living bodies and related diseases thereof.
  • active oxygen molecules such as superoxide, which is an oxygen molecule having an unpaired electron and relatively high reactivity, and derivatives thereof, including hydroxyradical and hydrogen peroxide. It is believed that these molecules oxidize intracellular target molecules such as membrane lipids, proteins, and DNAs to induce oxygen-related defects and cause aging of living bodies and related diseases thereof.
  • Enzymes capable of eliminating active oxygen such as superoxide dismutase (EC 1.15.1.1) and catalase (EC 1.11.1.6), and antioxidants such as L-ascorbic acid and ⁇ -tocopherol, exist in living cells, so that the concentration of intracellular active oxygen is kept generally at an extremely low level.
  • active oxygen such as superoxide dismutase (EC 1.15.1.1) and catalase (EC 1.11.1.6)
  • antioxidants such as L-ascorbic acid and ⁇ -tocopherol
  • Japanese Patent Kokai Nos. 168,435/93 and 143,466/96 proposed methods which comprise supplementing living bodies with active oxygen eliminating activity to promote the maintenance and promoting of health of living bodies by using a relatively high active oxygen eliminating activity of edible plants. It was confirmed that even if such edible plants were used, processing techniques such as juice extraction, extraction, heating, and drying, as well as successive storage conditions for the plants, may lower the inherent active oxygen eliminating activity or even extinguish this activity completely. There is a need for establishing a novel method for inhibiting the reductions of active oxygen eliminating activity without causing serious side effects in living bodies.
  • the object of the present invention is to provide a novel agent for reducing active oxygen eliminating activity, a composition which can be used by incorporating the agent into edible plant substances and/or plant antioxidants to inhibit their active oxygen eliminating activity, and a method for inhibiting the reduction of active oxygen eliminating activity of edible plant substances and/or plant antioxidants.
  • the present inventors studied the use of saccharides, and continued studying. They examined the influence of reduction of the inhibitory effect on active oxygen eliminating activity of plant substances with active oxygen eliminating activity such as edible plant substances and plant antioxidants by incorporating saccharides therein.
  • the first object of the present invention is to provide a reduction inhibitory agent for active oxygen eliminating activity which comprises trehalose as an effective ingredient.
  • the second object of the present invention is to provide a composition which can be obtained by incorporating the agent into edible plant substances and/or plant antioxidants with active oxygen eliminating activity to inhibit the reduction of their active oxygen eliminating activity.
  • the third object of the present invention is to provide a method for inhibiting the reduction of plant active oxygen eliminating activity which comprises incorporating the agent into plant substances with active oxygen eliminating activity.
  • the trehalose suitable used as an effective ingredient in the present reduction inhibitory agent for active oxygen eliminating activity is ⁇ , ⁇ -trehalose, although any trehalose can be used in the present invention independent of source or origin, as long as it inhibits the reduction of active oxygen eliminating activity.
  • trehaloses prepared from yeasts as disclosed in Japanese Patent Kokai No. 246,097/95, from maltose as disclosed in Japanese Patent Kokai Nos. 216,695/83 and 170,977/95, and from starch as disclosed in Japanese Patent Kokai Nos 143,876/95 and 213,283/95 can be used in the present invention.
  • trehalose such as syrup, crystalline powder of massecuite, crystalline hydrate, crystalline anhydride, or amorphous solid
  • Commercially available high purity crystalline trehalose hydrate and crystalline trehalose anhydride can be arbitrarily used.
  • the trehalose content in the present reduction inhibitory agent for active oxygen eliminating activity can be selected from those which exert a desired reduction inhibitory activity on the active oxygen eliminating activity of edible plant substance, usually, at least about 20 w/w % on a dry solid basis (d.s.b.), and preferably at least 50%, d.s.b.
  • % means w/w % unless otherwise specified.
  • the reduction inhibitory agent can be suitably incorporated into compositions containing edible plant substances and/or plant antioxidants in an amount of at least one percent, preferably at least 5 percent, and more preferably at least 20 percent, d.s.b.
  • the word “incorporating” in the present invention means “coexisting.”
  • any conventional methods can be used as long as they allow the agent to impart satisfactory reduction inhibitory activity for plant active oxygen eliminating activity independent of the incorporation methods and relative proportions.
  • the present agent can be preferably incorporated into plant edible substances and/or plant antioxidants by allowing the agent to contact the substances and/or the antioxidants in aqueous systems as homogeneously as possible.
  • the present agent in the form of a powder, crystal, or solid can be incorporated into the plant edible substances as homogeneously as possible by mixing with and dissolving in the substances.
  • the present agent While in the case of using edible plant substances and plant antioxidants in a solid form, they are treated with water to give a juicy form such as a liquid or suspension form, and are incorporated with the present agent by the above method or providing a syrup of the present agent and dispersing, dissolving, or suspending the edible plant substances and antioxidants in the syrup to allow contact with the agent as homogeneously as possible to incorporate the agent into the substances and antioxidants.
  • the present agent can be incorporated into the edible plant substances either by sprinkling the agent over the substances and mixing them to dissolve the present agent in the substances, or by soaking the edible plant substances in the agent in a syrup form.
  • the plant substances with active oxygen eliminating activity which can be used in the present invention include edible plants per se; disrupted, minced, pulverized, dried, and extracted products of edible parts of the edible plants; and/or plant antioxidants.
  • the edible plants suitably used in the present invention are edible root crops such as carrots, lotus roots, onions, burdocks, Japanese radishes, taros, and yams; leafy vegetables such as lettuces, chicories, Chinese cabbages, cabbages, kales, moreheiya or Corchorus olitorius, Angelica keiskei , spinach, Malabar nightshades, komatsuna (a kind of Chinese cabbage), nozawana (a kind of turnip), Chrysanthemum coronirium , chingensai (a Chinese vegetable), and turnips; fruiting vegetables such as okura or gumbos, cauliflowers, broccolis, eggplants, tomatoes, cucumbers, pumpkins, zucchini, green peppers, field peas,
  • plant antioxidants can be suitably selected and used as the present plant antioxidants: plant enzymes having active oxygen eliminating activity such as superoxide dismutase, catalase, and superoxide; plant pigments such as rutin, ⁇ -glycosyl rutin, hesperidin, ⁇ -glucosyl hesperidin, naringin, ⁇ -glucosyl naringin, chlorophyll, carotenoid, and anthocyanin; plant polyphenols such as gallic acid, catechin, ⁇ -glucosyl catechin, and tannic acid; and plant vitamins such as ⁇ -tocopherol, L-ascorbic acid, and riboflavin.
  • plant enzymes having active oxygen eliminating activity such as superoxide dismutase, catalase, and superoxide
  • plant pigments such as rutin, ⁇ -glycosyl rutin, hesperidin, ⁇ -glucosyl hesperidin, naringin, ⁇ -glu
  • the relatively low molecular weight plant antioxidants can be contained in the edible plants or added to the contents during processing of the edible parts of edible plants.
  • the plant antioxidants which exist separately from the edible plants, can be used in the present invention. Plant antioxidants should not be restricted to those which are extracted from plants, and include those which are artificially synthesized and produced.
  • Edible parts of edible plants are, for example,
  • compositions thus obtained are usually syrupy, pasty, or juicy disrupted products which have a relatively high moisture content and require a relatively low storage temperature for a satisfactory shelf life.
  • the compositions can be dried and/or pulverized, or dried and/or pulverized after sterilization by heating to obtain powdery or small pieces of solid compositions. Conventional drying and pulverizing methods can be arbitrarily used in the present invention.
  • the compositions of syrupy, pasty, or juicy disrupted products can be
  • the powdery products can be arbitrarily granulated, tabletted, and encapsulated into appropriate shapes and forms for use.
  • the solid compositions produces to such a high degree, will acquire more improved activity for inhibiting the reduction of active oxygen eliminating activity, storage stability, and handelability.
  • the solid compositions containing edible plant substances have features such that they effectively inhibit the deterioration of plant pigments contained in the edible plants, such as chlorophylls, carotenoids, anthocyanins, and flavonoids. Additionally, they satisfactorily retain the inherent color of the pigments and mask undesirable tastes such as bitterness and astringency.
  • compositions according to the present invention containing trehalose and a plant edible substance or plant antioxidant and which inhibit reduction of active oxygen eliminating activity can be further mixed with one or more appropriate substances in the form of a solid or liquid, such as essential minerals, edible fibers saccharides for promoting the growth of bifid bacteria, vitamins, biologically active substances, and preservatives.
  • Essential minerals which can be used in the present invention include, for example, calcium, magnesium, phosphorus, iron, copper, zinc, and cobalt. These minerals are used in an adequate amount.
  • Edible fibers which can be used in the present invention are, for example, pectin, alginic acid, carrageenan, gum Arabic, glucomannan, cyclodextrin, and pullulan.
  • pullulan in particular has a strong reduction inhibitory activity for —plant active oxygen eliminating activity when used in combination with trehalose as the effective ingredient according to the present invention. Based on this, pullulan can be most satisfactorily used together with trehalose in the present agent and used to produce compositions according to the present invention.
  • saccharides which can be used to promote the growth of bifid bacteria according to the present invention are lactosucrose, fructooligosaccharide, galactooligosaccharide, and isomaltooligosaccharide, which can arbitrarily used on demand.
  • Vitamins which can be used in compositions according to the present invention include, for example, water soluble vitamins such as thiamin, riboflavin, L-ascorbic acid, rutin, hesperidin, naringin, niacin, pyridoxine, cyanocobalamin, and derivatives thereof.
  • Lipid-soluble vitamins which can be used include vitamin A, vitamin D, ⁇ -tocopherol, vitamin K, and derivatives thereof.
  • compositions of the present invention can be incorporated into the compositions of the present invention, including hormones, antibiotics, cytokines, and propolis. Adequate amounts of ethanol, acetic acid, lactic acid and salt can optionally be used as preservatives in compositions according to the present invention.
  • compositions of the present invention can be used.
  • adequate coloring agents, flavoring agents, taste-imparting agents, stabilizers, fillers, adjuvants, and excipients can be used.
  • compositions thus obtained have at least five units/g composition, d.s.b., and preferably at least 10 units/g, d.s.b., of active oxygen eliminating activity as determined by the nitroblue tetrazolium (NBT) test.
  • NBT nitroblue tetrazolium
  • These compositions can easily administered to subjects via appropriate routes, including orally, intubationally, percutaneously, and permucosally to impart active oxygen eliminating activity with lesser deterioration of their quality.
  • Intake of the composition of the present invention containing plant edible substances enriches plant functional ingredients such as vitamins, mineral, and edible fibers inherent in the plants, and enriches living bodies with active oxygen eliminating activity.
  • compositions of the present invention can be satisfactorily used to maintain and promote health, prevent aging and geriatric diseases, promote the treatment of incurable diseases, and inhibit carcinogenesis.
  • the compositions of the present invention can be used in food products, cosmetics, pharmaceuticals, and their components and processing intermediates.
  • composition of the present invention can be used for health food products and other food products in general.
  • seasonings such as “furikaka” (a seasoned fish meal), sauces, ketchup, “yakinikui-no-tare” (a sauce for Japanese grilled meat).
  • compositions according to the present invention can be used in cosmetics such as skin-beautifying agents, packs, creams, shampoos, hair rinses, hair tonics, bath salts, enzymic agents, and tooth pastes in the form of a liquid, paste, powder, or granule; and used as a component of a processing intermediate for these products.
  • compositions according to the present invention can be used to treat age-related diseases in the form of an oral and/or intubation nutrient or therapeutic agent such as a coilunarium, nebula, digestive agent, stomachic, enzymic agent, ointment, cataplasm, and their components and processing intermediates.
  • an oral and/or intubation nutrient or therapeutic agent such as a coilunarium, nebula, digestive agent, stomachic, enzymic agent, ointment, cataplasm, and their components and processing intermediates.
  • compositions of the present invention comprises substantial food materials and can be used with less fear of causing toxicity.
  • the compositions can be used on a dry solid basis at a dose of about 0.1 to 1000 g/adult/day, preferably, about 0.2 to 500 g/adult/day, and more preferably, about 1 to 11 g/adult/day when administered orally.
  • compositions of the present invention can be administered to subjects intubationally, percutaneously, and permucosally in accordance with the oral dosage.
  • Fresh raw carrots were disrupted by a mixer, and 10% of either of saccharides, d.s.b., was added to the mixture and dissolved therein.
  • the solution was dried under reduced pressures at 40° C. for two days, dried in vacuo at the same temperature for 24 hours, and pulverized by a mixer into a powdery carrot composition.
  • the saccharides used were commercialized reagents of glucose, mannitol, sorbitol, maltose, sucrose, trehalose, and pullulan.
  • An about 100 g of the composition was placed and sealed in a 500-ml polystyrene container, and stored at 40° C. for seven days.
  • the active-oxygen eliminating activity of the composition before and after the storage were compared.
  • the assay for the active-oxygen eliminating activity followed the nitroblue tetrazolium test by Toshio IMANARI et al. in Igakuno Ayumi, Vol. 101, pp. 496-497 (1977); the level of superoxide, formed in a xanthine-xanthine oxidase system, was assayed by quantifying calorimetrically the content of formazan formed by reducing NBT. As a control, refined water was used as a test solution.
  • One unit activity of active-oxygen eliminating activity is defined as that inhibits 50% formazan formation as compared with the control.
  • Table 1 shows the composition of the powdery compositions, and the active-oxygen eliminating activity per gram of either of the compositions before and after the storage.
  • Table 1 shows the composition of the powdery compositions, and the active-oxygen eliminating activity per gram of either of the compositions before and after the storage.
  • the composition with trehalose showed the highest residual percentage for active-oxygen eliminating activity, revealing that trehalose exerts a strong effect on the reduction inhibitory activity for active-oxygen eliminating activity.
  • the reduction inhibitory activity of trehalose was strongly higher than that of glucose as the constituent saccharide for trehalose, and that of maltose as a disaccharide consisting of two glucose units similar to trehalose.
  • trehalose is suitably used as an effective ingredient for a reduction inhibitory agent for active-oxygen eliminating activity.
  • Vegetables were treated similarly as in Experiment 1, and 10% trehalose, d.s.b., to the disrupted vegetables. The resulting mixture was dried in vacuo at 45° C. for 20 hours, and pulverized into a powdery vegetable composition. Similarly as in Experiment 1, each composition was respectively placed in a container and stored at 40° C. for six days. The active-oxygen eliminating activity of one gram of each composition before and after the storage was compared with that of the composition prepared without trehalose. Table 3 shows the composition of the powdery compositions, and their active-oxygen eliminating activity.
  • compositions were placed in a glass test tube, sealed with a rubber cap, and stored under light-shielded conditions.
  • water was used in place of the trehalose solution.
  • Table 4 shows the active-oxygen eliminating activity before and after the storage. As shown in Table 4, it was confirmed that trehalose exerts an effective reducing inhibitory activity for active-oxygen eliminating activity of plant antioxidants such as superoxide dismutase, ⁇ -glucosyl hesperidin, ⁇ -glucosyl rutin, gallic acid, and catechin.
  • composition with trehalose and pullulan had an activity of about 4,300 units/g composition, while the composition with dextrin had an activity of about 3,100 units/g composition.
  • the data shows that the use of trehalose and pullulan exerts a higher reduction inhibitory effect for active-oxygen eliminating activity than in the case of using dextrin.
  • Corn starch was prepared into an about 33% starch suspension which was then mixed with 0.1% calcium carbonate, adjusted to pH 6.5, mixed with 0.3 per g starch of “TERMAMYL”, an ⁇ -amylase specimen commercialized by Novo Industri A/S Copenhagen, Denmark, enzymatically reacted at 95° C. for 15 min, autoclaved at 120° C., and promptly cooled to obtain a liquefied solution with DE of about four.
  • the liquefied solution was admixed with four units/g starch, d.s.b., of respective non-reducing saccharide-forming enzyme and trehalose-releasing enzyme, prepared by culturing a microorganism of the genus Rhizobium by the method in Japanese Patent Kokai No. 213,283/93, 500 units/g starch of isomaylase, and five units/g starch of cyclomaltodextrin glucanotransferase, adjusted to pH 6.2, and enzymatically reacted at 40° C. for 48 hours.
  • the reaction mixture was heated to inactivate the remaining enzymes, then admixed with 10 unites/g substrate of glucoamylase and enzymatically reacted at pH 5.0 and 50° C. for 10 hours.
  • the reaction mixture thus obtained contained about 86% trehalose, d.s.b.
  • the mixture was heated to inactivate the remaining enzyme, then in a conventional manner purified by decoloring and desalting, and continuously crystallized while concentrating.
  • the resulting massecuite was separated by a basket-type centrifuge, and the crystal was washed by spraying with a small amount of water to obtain a crystalline trehalose hydrate with a purity of 98% or higher in a yield of about 64%, d.s.b.
  • the product is a crystalline trehalose hydrate with a considerably-high purity and suitably used as the present reduction inhibitory agent and advantageously used to inhibit the reduction of active-oxygen eliminating activity of plant edible substances.
  • a microorganism of the genus Thermus capable of producing a maltose/trehalose converting enzyme was cultured in a nutrient culture medium by the method in Japanese Patent Kokai No. 170,977/95. After completion of the culture, the proliferated cells were collected by centrifugation to obtain 250 g wet cells having a total activity of about 7,500 units. The cells were immobilized using sodium alginate solution and calcium chloride solution to obtain alginic acid-immobilized cells. A jacketed-glass column, 5.4 cm in diameter and 100 cm in length, injected with the immobilized cells, and kept at 60° C.
  • a 40% maltose solution (pH 6.5) was fed to the column at SV (space velocity) 0.2 by the descending method to obtain a reaction mixture containing about 66% trehalose, about 28% maltose, and about 6% glucose.
  • the reaction mixture was in a conventional manner purified by decoloring and desalting, concentrated in vacuo into an about 75% syrup which was then placed in crystallizer, admixed with about one percent of respective seed crystals of crystalline trehalose hydrate and crystalline maltose hydrate, and cooled to obtain a massecuite with a crystallization degree of about 25%.
  • the massecuite was spray dried and aged to obtain a powdery crystalline saccharide in a yield of about 92% to the material maltose, d.s.b.
  • the powdery saccharide is a stable powdery saccharide, which has a crystallization degree of about 60% and contains about 66% trehalose, about 28% maltose, and about six % glucose, and it can be suitably used as a reduction inhibitory agent for active-oxygen eliminating activity and arbitrarily used to inhibit the reduction of active-oxygen eliminating activity of plant edible substances.
  • Potato starch was prepared into a 10% starch suspension which was then subjected to the action of ⁇ -amylase to obtain a liquefied solution.
  • To the liquefied solution were added three units/g starch, d.s.b., or a non-reducing saccharide-forming enzyme disclosed in Japanese Patent Kokai No.
  • the product is a stable syrup, which contains, on a dry solid basis, about 50% trehalose along with other saccharides derived from starch, can be suitably used as a reduction inhibitory agent for active-oxygen eliminating activity, and arbitrarily used to inhibit the reduction of active-oxygen eliminating activity of plant edible substances.
  • Example A-1 One hundred parts by weight of a high-purity crystalline trehalose hydrate, obtained by the method in Example A-1, was mixed to homogeneity with one part by weight of pullulan to produce a solid reduction inhibitory agent for active-oxygen eliminating activity.
  • the product can be arbitrarily used in a reduction inhibitory agent for active-oxygen eliminating activity of plant edible substances.
  • Fresh spinach was pulverized by a mixer, and in 10 parts by weight of the resulting disruptant were dissolved by mixing one part by weight of a reduction inhibitory agent for active-oxygen eliminating activity obtained by the method in Example A-4, and 0.1 part by weight of ⁇ -glucosyl rutin.
  • the resulting mixture was heated at 100° C. for 10 min, dried with air heated to 40° C. for two hours, dried in vacuo at 40° C. for 16 hours, and powdered by a pulverizer to obtain a composition containing spinach having an active-oxygen eliminating activity of about 1,200 units/g composition.
  • the composition retained satisfactorily the inherent color of spinach and stimulated the appetite. Intake of the composition enriches living bodies with functional ingredients such as vitamins, minerals, and edible fibers inherent to the spinach, and imparts the active-oxygen eliminating activity to the living bodies.
  • the composition can be satisfactorily used to maintain and promote health, prevent aging and geriatric diseases, promote the treatment of incurable diseases, and prevent carcinogenesis.
  • the composition can be arbitrarily used as a food product, cosmetic, pharmaceutical, or their material or processing intermediates.
  • Cabbage was cut, branched, sliced by a cutter into fine strips about 5 mm wide. Ten parts by weight of the fine strips was mixed with one part by weight of a reduction inhibitory agent for active-oxygen eliminating activity obtained by the method in Example A-3, and 0.05 part by weight of ⁇ -glucosyl rutin, and the mixture was allowed to stand at ambient temperature for two hours, then dried by air heated to 40° C. for two hours, dried in vacuo at 40° C. for 16 hours to obtain a composition containing fine strips of cabbage having an active-oxygen eliminating activity of about 1,300 units/g composition. The composition retained satisfactorily the inherent color of the cabbage and stimulated your appetite.
  • Intake of the composition enriches living bodies with functional ingredients such as vitamins, and edible fibers inherent to the cabbage, and imparts the active-oxygen eliminating activity to the living bodies.
  • the composition can be satisfactorily used to maintain and promote health, prevent aging and geriatric diseases, promote the treatment of incurable diseases, and prevent carcinogenesis.
  • the composition can be arbitrarily used as a food product, cosmetic, pharmaceutical, or their material or processing intermediates.
  • a fresh eggplant was sliced, and the sliced eggplant was washed with water.
  • One part by weight of a reduction inhibitory agent for active-oxygen eliminating activity obtained by the method in Example A-1, was mixed with and dissolved in 10 parts by weight of the sliced eggplant, and the resulting mixture was dried by air heated to 70° C. for two days to obtain a composition containing sliced eggplant having an active-oxygen eliminating activity of about 11,000 units/g composition.
  • the composition retained the inherent color of the eggplant's skin and stimulated the appetite. Intake of the composition enriches living bodies with functional ingredients such as vitamins, minerals, and edible fibers inherent to the eggplant, and imparts the active-oxygen eliminating activity to the living bodies.
  • the composition can be satisfactorily used to maintain and promote health, prevent aging and geriatric diseases, promote the treatment of incurable diseases, and prevent carcinogenesis.
  • the composition can be arbitrarily used as a food product, cosmetic, pharmaceutical, or their material or processing intermediates.
  • a fresh carrot was branched and sliced by a slicer.
  • One part by weight of a reduction inhibitory agent for active-oxygen eliminating activity obtained by the method in Example A-4, was added to 10 parts by weight of the sliced carrot and dissolved therein.
  • the mixture was dried with air heated to 50° C. for 16 hours to obtain a composition containing sliced carrots having an active-oxygen eliminating activity of about 450 units/g composition.
  • the composition satisfactorily retained the color inherent to the carrot, stimulated the appetite, and had a relatively-low hygroscopicity and a satisfactory shelf-life.
  • Intake of the composition enriches living bodies with functional ingredients such as vitamins, minerals, and edible fibers inherent to the carrot, and imparts the active-oxygen eliminating activity to the living bodies.
  • the composition can be satisfactorily used to maintain and promote health, prevent aging and geriatric diseases, promote the treatment of incurable diseases, and prevent carcinogenesis.
  • the composition can be arbitrarily used as a food product, cosmetic, pharmaceutical, or their material or processing intermediates.
  • Dried Hizikia fusiforme was rehydrated in water and disrupted with a cutter.
  • 10 parts by weight of the disrupted mixture was dissolved by mixing five parts by weight of a reduction inhibitory agent for active-oxygen eliminating activity obtained by the method in Example A-2.
  • the solution was dried by air heated to 50° C. for eight hours, dried in vacuo at 40° C., and pulverized into a composition containing Hizikia fusiforme having an active-oxygen eliminating activity of about 24 units/g composition.
  • Intake of the composition enriches living bodies with functional ingredients such as vitamins, minerals, and edible fibers inherent to Hizikia fusiforme , and imparts the active-oxygen eliminating activity to the living bodies.
  • the composition can be satisfactorily used to maintain and promote health, prevent aging and geriatric diseases, promote the treatment of incurable diseases, and prevent carcinogenesis.
  • the composition can be arbitrarily used as a food product, cosmetic, pharmaceutical, or their material or processing intermediates.
  • a dried shiitake mushroom was rehydrated in water, heated at 100° C. for 15 min, and disrupted by a cutter.
  • 100 parts by weight of the disrupted mixture was dissolved by mixing 0.1 part by weight of a tea extract and 10 parts by weight of a reduction inhibitory agent for active oxygen eliminating activity obtained by the method in Example A-3, and the resulting mixture was dried at 50° C. for eight hours, dries in vacuo at 40° C., and pulverized to obtain a composition containing a powdery shiitake mushroom having an active-oxygen eliminating activity of about 560 units/g composition.
  • Intake of the composition enriches living bodies with functional ingredients such as vitamins, minerals, and edible fibers inherent to Hizikia fusiforme , and imparts the active-oxygen eliminating activity to the living bodies.
  • the composition can be satisfactorily used to maintain and promote health, prevent aging and geriatric diseases, promote the treatment of incurable diseases, and prevent carcinogenesis.
  • the composition can be arbitrarily used as a food product, cosmetic, pharmaceutical, or their material or processing intermediates.
  • Citron rind was disrupted by a cutter, and five parts by weight of the disrupted rind was mixed with one part by weight of a reduction inhibitory agent for active-oxygen eliminating activity, obtained by the method in Example A-1, to dissolve the agent therein. After preliminary freezing, the resulting mixture was freeze-dried for three days, and disrupted to obtain a composition containing a powdery citron having an active-oxygen eliminating activity of about 12 units/g composition. The composition retains satisfactorily the color and flavor inherent to the citron. Intake of the composition enriches living bodies with functional ingredients such as vitamins, minerals, and edible fibers inherent to the citron, and imparts the active-oxygen eliminating activity to living bodies.
  • the composition can be satisfactorily used to maintain and promote health, prevent aging and geriatric diseases, promote the treatment of incurable diseases, and prevent carcinogenesis.
  • the composition can be arbitrarily used as a food product, cosmetic, pharmaceutical, or their material or processing intermediates.
  • a fresh ginger was disrupted by a mixer.
  • the disrupted mixture was dissolved by mixing one part by weight of a reduction inhibitory agent for active-oxygen eliminating activity obtained by the method in Example A-2.
  • the resulting mixture was freeze-dried for three days, and disrupted by a crusher to obtain a composition containing a powdery ginger having an active-oxygen eliminating activity of about 120 units/g composition.
  • Intake of the composition enriches living bodies with functional ingredients such as vitamins, minerals, and edible fibers inherent to the ginger, and imparts the active-oxygen eliminating activity to the living bodies.
  • the composition can be satisfactorily used to maintain and promote your health, prevent aging and geriatric diseases, promote the treatment of incurable diseases, and prevent carcinogenesis.
  • the composition can be arbitrarily used as a food product, cosmetic, pharmaceutical, or their material or processing intermediates.
  • composition Containing Aojiso (a Beefsteak Plant)
  • Aojiso leaves were branched and disrupted by a mixer.
  • the disrupted mixture was dissolved by mixing one part by weight of a reduction inhibitory agent for active-oxygen eliminating activity obtained by the method in Example A-4, and 0.5 part by weight of ⁇ -glucosyl rutin, then mixed with 49 parts by weight of crystalline trehalose anhydride as a desiccant.
  • the resulting mixture was allowed to stand at ambient temperature for one day and disrupted by a crusher to obtain a composition containing a powdery aojiso having an oxygen eliminating activity of about 230 units/g composition.
  • the composition satisfactorily retained the color, flavor and taste of the aojiso, and stimulated the appetite.
  • Intake of the composition enriches living bodies with functional ingredients such as vitamins, minerals, and edible fibers inherent to the aojjiso, and imparts the active-oxygen eliminating activity to living bodies.
  • the composition can be satisfactorily used to maintain and promote health, prevent aging and geriatric diseases, promote the treatment of incurable diseases, and prevent carcinogenesis.
  • the composition can be arbitrarily used as a food product, cosmetic, pharmaceutical, or their material or processing intermediates.
  • mugwort was placed into boiling water with an adequate amount of salt to remove harshness, dehydrated softly and disrupted by a crusher.
  • Five parts by weight of the disrupted mixture was mixed with 0.05 part by weight of ⁇ -glucosyl rutin and 1.3 parts by weight of a reduction inhibitory agent for active-oxygen eliminating activity obtained by the method in Example A-5.
  • the resulting mixture was dried by air heated to 50° C. for four hours, dried in vacuo at 40° C. for 16 hours, and disrupted to obtain a composition containing a powdery mugwort having an active-oxygen eliminating activity of about 780 units/g composition.
  • the composition satisfactorily retained the color, flavor and taste of the mugwort, and stimulated the appetite.
  • Intake of the composition enriches living bodies with functional ingredients such as vitamins, minerals, and edible fibers inherent to mugwort, and imparts the active-oxygen eliminating activity to the living bodies.
  • the composition can be satisfactorily used to maintain and promote health, prevent aging and geriatric diseases, promote the treatment of incurable diseases, and prevent carcinogenesis.
  • the composition can be arbitrarily used as a food product, cosmetic, pharmaceutical, or their material or processing intermediates.
  • composition Containing Dokudami a Bad-smelling Perennial Plant of the Family Saururaceae
  • a half part by weight of a dried dokudami was mixed with 10 parts by weight of water, and heated to boiling for 90 min. A supernatant of the infused solution was collected by a basket-type centrifuge and boiled down to obtain four parts by weight of about five w/v % solution. Two parts by weight of he concentrate was mixed with 0.5 part by weight of a reduction inhibitory agent for active-oxygen eliminating activity obtained by the method in Example A-4, and the resulting solution was spray-dried in a conventional manner to obtain a composition containing a powdery dokudami extract having an active-oxygen eliminating activity of about 1,400 units/g composition.
  • the composition had a lesser unsatisfactory smell and taste inherent to the dokudami and could be more easily swallowable than conventional ones. Intake of the composition enriches living bodies with functional ingredients such as vitamins, minerals, an edible fibers inherent to the dokudami, and imparts the active-oxygen eliminating activity to living bodies.
  • the composition can be satisfactorily used to maintain and promote health, prevent aging and geriatric diseases, promote the treatment of incurable diseases, and prevent carcinogenesis.
  • the composition can be arbitrarily used as a food product, cosmetic, pharmaceutical, or their material or processing intermediates.
  • a fresh aloe was disrupted by a mixer, and 10 parts by weight of the disrupted aloe was mixed with 0.1 part by weight of a tea extract and one part by weight of a reduction inhibitory agent for active-oxygen eliminating activity obtained by the method in Example A-1.
  • the resulting mixture was dried by air, heated to 70° C. for two days, and disrupted by a crusher to obtain a composition containing a powdery aloe having an active-oxygen eliminating activity of 5,800 units/g composition.
  • the composition had a lesser astringency of the aloe and was more easily swallowable than conventional ones.
  • Intake of the composition enriches living bodies with functional ingredients such as vitamins, minerals, and edible fibers inherent to the aloe, and imparts the active-oxygen eliminating activity to living bodies.
  • the composition can be satisfactorily used to maintain and promote health, prevent aging and geriatric diseases, promote the treatment of incurable diseases, and prevent carcinogenesis.
  • the composition can be arbitrarily used as a food product, cosmetic, pharmaceutical, or their material or processing intermediates.
  • a Chinese cabbage preserved with seasonings was cut. To 10 parts by weight of the cut product was added and dissolved therein one part by weight of a reduction inhibitory agent for active-oxygen eliminating activity obtained by the method in Example A-1, and the mixture was dried with air heated to 55° C. for 16 hours to obtain a composition containing small pieces of Chinese cabbage, preserved with seasonings, having an active-oxygen eliminating activity of about 5,400 units/g composition. The product retained the color tint of the Chinese cabbage. When tasted, the satisfactory taste and flavor spread throughout the mouth and stimulated the appetite. Intake of this composition enriches living bodies with functional ingredients such as vitamins, minerals, and edible fibers inherent to the Chinese cabbage, and augments the active oxygen eliminating activity to the living bodies.
  • compositions can be satisfactorily used to maintain and promote health, prevent aging and geriatric disease, promote the treatment of incurable diseases, and prevent carcinogenesis.
  • the composition can be used as a food product, cosmetic, pharmaceutical, or a component of processing intermediate thereof.
  • the compositions can also be used as food products such as furikake, premix for onigiri (a rice ball), and soup for Chinese noodles, and as a health food, cosmetic, pharmaceutical, or components and intermediates thereof.
  • a pickled nozawana was subjected to a cutter. To 10 parts by weight of the cut product was added and dissolved therein one part by weight of a reduction inhibitory agent for active oxygen eliminating activity obtained by the method in Example A-1. The mixture was dried in air, heated to 55° C. for 16 hours to obtain a composition containing small pieces of pickled nozawana having an active oxygen eliminating activity of about 2600 units/g composition. The product retained the color tint of the picked nozawana. When tasted, the satisfactory taste and flavor spread throughout the mouth and stimulated the appetite. Intake of this composition enriches living bodies with functional ingredients such as vitamins, minerals and edible fibers inherent to the pickled nozawana, and augments the active oxygen eliminating activity to the living bodies. The composition can be used to maintain and promote health, prevent aging and geriatric diseases, promote treatment of incurable diseases, and prevent carcinogenesis. Thus, the composition can be used as a food product, cosmetic, pharmaceutical, or components or processing intermediates thereof.
  • Korean pickled Chinese cabbage was cut. To ten parts by weight of the cut product was added and dissolved therein was added one part by weight of a reduction inhibitory agent for active oxygen eliminating activity obtained by the method of Example A-4. The mixture was air dried and heated to 55° C. for 16 hours to produce a composition containing small pieces of pickled Chinese cabbage having an active oxygen eliminating activity of about 1600 units/g composition. The product retained the color tine of Korean pickled Chinese cabbage. When tasted, the satisfactory taste and flavor spread throughout the mouth and stimulated the appetite. Intake of the composition enriches living bodies with functional ingredients such as vitamins, minerals, and edible fibers inherent to Korean picked Chinese cabbage, and augments the active oxygen eliminating activity to the living bodies. The composition can be used to maintain and promote health, prevent aging and geriatric disease, promotes the treatment of incurable diseases, and prevent carcinogenesis. Thus, the composition can be used as a food product, cosmetic, pharmaceutical, or components or processing intermediates thereof.
  • Soybeans were soaked in five-fold volumes of water overnight and drained. Ten parts by weight of the soaked soybeans was placed into a pan, mixed with 35 parts by weight of a reduction inhibitory agent for active oxygen eliminating activity obtained by the method of Example A-1, and 35 parts by weight of water. The mixture was boiled over mild heat to produce a concentration of about 70% as determined by a brix apparatus and to obtain boiled beans. The beans were placed into a basket and dried with air heated to 40° C. overnight to product a composition containing soy beans having an active oxygen eliminating activity of about 25 units/g of composition. The product retained the color tint of the boiled soybeans. When tasted, the taste and flavor spread throughout the mouth and stimulated the appetite.
  • trehalose hydrate is present within the soybeans' tissues, and the hydrate retained the issues.
  • the product was a solid food having satisfactory taste and mouth feel. Intake of the composition enriches living bodies with functional ingredients such as vitamins, minerals and edible fibers inherent in the soybeans, and augments the active oxygen eliminating activity to living bodies.
  • the composition can be used to maintain and promote health, prevent aging and geriatric disease, promote the treatment of incurable diseases, and prevent carcinogenesis.
  • the composition can be used as a food product, cosmetic, pharmaceutical, or components or processing intermediates thereof.
  • Fresh apples were peeled and sliced to produce slices about 5 mm in thickness, which were then soaked for 30 minutes in an about 75% solution prepared by dissolving a reduction inhibitory agent for active oxygen eliminating activity obtained by the method in Example A-1 in water by heating at 80° C.
  • the apples and solution were placed into a basked and dried at 35° C. overnight to obtain a composition containing apples having an active oxygen eliminating activity of about 50 units/g composition.
  • the production retained the color tint of apples. When tasted, the taste and flavor spread throughout the mouth and stimulated the appetite.
  • trehalose hydrate is present within the apples' tissues, and the hydrate retained the tissues.
  • the product was a solid food having satisfactory taste and mouth feel.
  • the composition can be used to maintain and promote health, prevent aging and geriatric disease, promote the treatment of incurable diseases, and prevent carcinogenesis.
  • the composition can be used as a food product, cosmetic, pharmaceutical, or components or processing intermediates thereof.
  • the composition was a fried-like product of carrot, to which crystalline trehalose hydrate adhered. It retained the inherent color to carrot and stimulated the appetite.
  • the product had a relatively low hygroscopicity, satisfactory shelf life, and desirable handle ability. Intake of the composition enriches living bodies with functional ingredients such as vitamins, minerals and edible fibers inherent in the carrots, and augments the active oxygen eliminating activity to living bodies.
  • the composition can be used to maintain and promote health, prevent aging and geriatric disease, promote the treatment of incurable diseases, and prevent carcinogenesis.
  • the composition can be used as a food product, cosmetic, pharmaceutical, or components or processing intermediates thereof.
  • Fresh apples were peeled and sliced to a thickness of about 5 mm. Four parts by weight of the sliced apples was then placed into an about 80% syrup heated to about 110° C., which had been prepared by dissolving by heating in water 140 parts by weight of a reduction inhibitory agent for active oxygen eliminating activity obtained by the method of Example A-1 and concentrated by boiling at a temperature of about 114° C. for about 10 minutes and dehydrated by heating to produce a fried-like product. Thereafter, the product was placed into a basket, dried by air heated to 35° C. overnight to product a composition containing sliced applied having an active oxygen eliminating activity of about 30 units/g composition. The composition was a fried-like apple product, to which crystalline trehalose hydrate adhered.
  • the composition can be used to maintain and promote health, prevent aging and geriatric disease, promote the treatment of incurable diseases, and prevent carcinogenesis.
  • the composition can be used as a food product, cosmetic, pharmaceutical, or components or processing intermediates thereof.
  • Example B-10 Ten parts by weight of glutinous rice starch was mixed with 12 parts by weight of water, and the mixture was gelatinized by heating, then kneaded with 0.5 part by weight of a composition containing mugwort obtained by the method of Example B-10. The mixture thus obtained was shaped and packaged in a conventional manner to produce a dango having an active oxygen eliminating activity of over 12 units/g content.
  • the product is a yomogi-dango, i.e., a rice paste with mugwort, having a satisfactory color tint of yomogi, flavor, taste, and mouth feel.
  • a composition was prepared from the following ingredients: 10 parts by weight of crystalline ⁇ -maltose, 1.1 parts by weight of glycine, 0.18 part by weight of sodium glutamate, 1.2 parts by weight of salt, one part by weight of citric acid, 0.4 part by weight of calcium lactate, 0.3 part by weight of a composition containing spinach obtained by the method of Example B-1, 0.01 part by weight of thiamine, and 0.01 part by weight of riboflavin. Twenty four gram aliquots of the composition were injected into small laminated aluminum bags and heat sealed to obtain a nutritional product for intubtaion having an active oxygen eliminating activity of over 12 units/g composition. One bag of the nutritional product is dissolved in about 300-500 ml of water, and the solution can be administered to subjects orally or through the subjects' nasal cavities, stomachs, or intestines as a parenteral liquid nutritional supplement.
  • the resulting solution was admixed with two parts by weight of L-lactic acid, five parts by weight of 1,3-butylene glycol and 66 parts by weight of refined water, and the mixture was emulsified by a homogenizer and admixed with an adequate amount of a flavor under stirring to obtain a cosmetic cream having an active oxygen eliminating activity of over 46 units/g product.
  • the product can be used as a therapeutic or preventive agent for sunburned skin, as a skin beautifying agent, a skin whitening agent, and an agent for inhibiting aging of skin including chloasmas, freckles, pigmentation, and wrinkles.
  • Bath salts having an active oxygen eliminating activity of over 220 units/g product were prepared by mixing 26 parts by weight of refined water and adequate amounts of a coloring agent and flavoring agent with 21 parts by weight of sodium DL-lactate, eight parts by weight of sodium pyruvate, five parts by weight of a composition containing citron obtained by the method of Example B-7, one part by weight of ⁇ -glucosyl rutin, and 40 parts by weight of ethanol.
  • the product can be suitable used as a skin beautifying agent and skin whitening agent by diluting 100-10,000 fold in hot water in a bathtub. Similarly as above, the product can be used by diluting it in water for a face wash or beauty wash.
  • One part by weight of sodium acetate trihydrate and four parts by weight of calcium DL-lactate were mixed to homogeneity with 10 parts by weight of glycerin, and this mixture was added to a mixture consisting of 50 parts by weight of petrolatum, 10 parts by weight of vegetable wax, five parts by weight of lanolin, 14.5 parts by weight of sesame oil, six parts by weight of a composition containing dokudami obtained by the method of Example B-11, and 0.5 part by weight of peppermint oil.
  • the mixture thus obtained was further mixed to homogeneity into an ointment having an active oxygen eliminating activity of about 54 units/g.
  • the product can be used as an antipyogenic agent, skin beautifying agent, skin whitening agent, and agent for promoting the treatment of skin traumas and burns.
  • the present invention provides a reduction inhibitory agent for active oxygen eliminating activity which comprises trehalose as an effective ingredient, a method for inhibiting the reduction of active oxygen eliminating activity comprising incorporating either trehalose or the reduction inhibitory agent into products to be treated, and a composition which contains plant edible substance and/or plant antioxidant in which the reduction of active oxygen eliminating activity is inhibited by the above method.
  • Intake of the present composition easily nutritionally supplements living bodies and enriches living bodies with functional ingredients such as vitamins, minerals, and edible fibers of plant edible substances. Therefore, the present composition contributes greatly to maintain and promote health, prevent aging and geriatric diseases promote the treatment of incurable diseases, and inhibit carcinogenesis.
  • the present invention provides a novel health resource as a fourth functional ingredient which can be used in processing and use of plant edible substances.
  • the present invention provides a great contribution to a wide variety of fields, particularly the fields of food products, cosmetics, and pharmaceuticals.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines Containing Plant Substances (AREA)
US09/984,392 1997-03-04 2001-10-30 Reduction inhibitory agent for active oxygen eliminating activity Abandoned US20020055620A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09/984,392 US20020055620A1 (en) 1997-03-04 2001-10-30 Reduction inhibitory agent for active oxygen eliminating activity

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP6398797 1997-03-04
JP63987/1997 1997-03-04
JP17647/1998 1998-01-14
JP1764798 1998-01-14
US3433698A 1998-03-04 1998-03-04
US09/984,392 US20020055620A1 (en) 1997-03-04 2001-10-30 Reduction inhibitory agent for active oxygen eliminating activity

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US3433698A Division 1997-03-04 1998-03-04

Publications (1)

Publication Number Publication Date
US20020055620A1 true US20020055620A1 (en) 2002-05-09

Family

ID=26354207

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/984,392 Abandoned US20020055620A1 (en) 1997-03-04 2001-10-30 Reduction inhibitory agent for active oxygen eliminating activity
US10/670,525 Expired - Fee Related US7186824B2 (en) 1997-03-04 2003-09-26 Reduction inhibitory agent for active-oxygen eliminating activity

Family Applications After (1)

Application Number Title Priority Date Filing Date
US10/670,525 Expired - Fee Related US7186824B2 (en) 1997-03-04 2003-09-26 Reduction inhibitory agent for active-oxygen eliminating activity

Country Status (4)

Country Link
US (2) US20020055620A1 (fr)
EP (1) EP0868916A3 (fr)
KR (1) KR19980079895A (fr)
TW (1) TW466116B (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040223942A1 (en) * 2003-03-06 2004-11-11 Kao Corporation Skin aging-preventing or improving agent
US20050053555A1 (en) * 2003-07-14 2005-03-10 Crave Busters, Llc. Appetite control compositions and methods of use
US6989161B2 (en) 2000-06-12 2006-01-24 Access Business Group International Llc Phytonutrient nutritional supplement
US20080069910A1 (en) * 2005-02-03 2008-03-20 Tsutomu Okubo Preventive, Relieving or Therapeutic Composition for Diabetes Mellitus and/or Diabetic Nephropathy

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW466116B (en) 1997-03-04 2001-12-01 Hayashibara Biochem Lab Reduction inhibitory agent for active-oxygen eliminating activity, method for inhibiting the reduction of said activity, and composition containing said agent
JP4295840B2 (ja) * 1997-12-09 2009-07-15 株式会社林原生物化学研究所 血行改善剤
JP3958884B2 (ja) 1998-09-11 2007-08-15 株式会社林原生物化学研究所 非還元性糖質生成酵素及びトレハロース遊離酵素ならびに該酵素を用いる糖質の製造方法
DE19938277A1 (de) * 1999-08-12 2001-02-22 Gert Wetterauer Repellin DW
US6630175B1 (en) 2000-06-29 2003-10-07 Johnson & Johnson Consumer Companies, Inc. Method of reducing eye irritation
US6649176B1 (en) 2000-06-29 2003-11-18 Johnson & Johnson Consumer Companies, Inc. Compositions containing mineral water
US6372791B1 (en) 2000-06-29 2002-04-16 Johnson & Johnson Consumer Companies, Inc. Method of promoting skin cell metabolism
US6432424B1 (en) 2000-06-29 2002-08-13 Johnson & Johnson Consumer Companies, Inc. Cosmetic compositions containing creatine, carnitine, and/or pyruvic acid
KR20030006856A (ko) * 2001-07-16 2003-01-23 이충우 여드름균 생육 저해제
JP4132767B2 (ja) 2001-07-19 2008-08-13 株式会社林原生物化学研究所 プルラン含有粉末とその製造方法並びに用途
CN100436466C (zh) * 2001-08-10 2008-11-26 株式会社林原生物化学研究所 海藻糖或麦芽糖醇和金属离子化合物的缔合物
JP4397142B2 (ja) * 2001-11-20 2010-01-13 株式会社林原生物化学研究所 活性酸素消去能低減抑制剤
FR2837383B1 (fr) * 2002-03-21 2006-05-19 Gelyma Utilisation d'un extrait de l'algue undaria pinnatifida dans des compositions cosmetiques ou dermopharmaceutiques actives contre les especes radicalaires de l'oxygene et divers types de pollutions
KR100515923B1 (ko) * 2002-10-22 2005-09-21 이환업 바이오 복합 단백질 조성방법
KR20040035504A (ko) * 2002-10-22 2004-04-29 이환업 해독, 항산화 기능 작용, 흡연 억제 기능 작용을 하는바이오 복합 단백질 조성방법
WO2005103193A1 (fr) * 2004-03-30 2005-11-03 Shishiai-Kabushikigaisha Composition de support de chauffage
KR20070011608A (ko) * 2004-05-17 2007-01-24 가부시끼가이샤 하야시바라 세이부쓰 가가꾸 겐꾸조 수계 환경과 접하는 생체의 생명활동의 강화 및/또는생명활동에 적합한 영역을 확장하는 방법
KR100720381B1 (ko) 2005-12-14 2007-05-22 이금희 클렌징 화장료 조성물
KR100758708B1 (ko) 2006-09-07 2007-09-14 김정선 스킨로션 및 그 제조방법
KR100835866B1 (ko) * 2007-01-05 2008-06-09 (주)아모레퍼시픽 항산화 물질의 산화촉진 부작용을 감소시키는 방법
KR100811298B1 (ko) * 2007-02-02 2008-03-07 김정선 스킨로션 및 그 제조방법
EP2198869B1 (fr) * 2007-02-23 2015-09-16 Next 21 K.K. Tréhalose pour le traitement ou la prévention du vasospasme
EP2663294B1 (fr) 2011-01-11 2015-09-30 Capsugel Belgium NV Nouvelles gélules dures comprenant du pullulane
WO2013112897A1 (fr) 2012-01-27 2013-08-01 The Regents Of The University Of California Stabilisation de biomolécules au moyen de polymères de glucides
CN104689148A (zh) * 2015-01-22 2015-06-10 鲁彩霞 一种用于调理人体血热的冲剂饮品及其生产工艺
JP7222911B2 (ja) 2017-04-14 2023-02-15 カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップ プルランを作製する方法
AU2018251256B2 (en) 2017-04-14 2023-10-05 Capsugel Belgium Nv Pullulan capsules

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58216695A (ja) 1982-06-07 1983-12-16 Otsuka Shokuhin Kogyo Kk トレハロ−スの製造方法
JPH0677019B2 (ja) * 1984-01-17 1994-09-28 株式会社ヤトロン 酵素標識抗体の安定化法
DE3542309A1 (de) 1985-11-29 1987-06-04 Cardona Federico Dr Medizinisches antioxidativum
US4806343A (en) * 1986-03-13 1989-02-21 University Of Southwestern Louisiana Cryogenic protectant for proteins
US4839164A (en) * 1987-02-24 1989-06-13 Estee Lauder, Inc. Trehalose containing cosmetic composition and method of using it
GB8715238D0 (en) * 1987-06-29 1987-08-05 Quadrant Bioresources Ltd Food process
JPH01106829A (ja) * 1987-10-21 1989-04-24 Tosoh Corp スーパーオキサイドジスムターゼ保持リポソーム製剤の凍結乾燥法
US4915951A (en) * 1987-12-03 1990-04-10 California Institute Of Technology Cryoprotective reagent
GB8801338D0 (en) * 1988-01-21 1988-02-17 Quadrant Bioresources Ltd Preservation of viruses
JPH01304882A (ja) * 1988-06-03 1989-12-08 Ube Ind Ltd ヒトＣｕ，Ｚｎ型スーパーオキシドジスムターゼの安定保存法
US5059518A (en) * 1988-10-20 1991-10-22 Coulter Corporation Stabilized lyophilized mammalian cells and method of making same
US4963385A (en) * 1989-06-02 1990-10-16 Nabisco Brands, Inc. Stabilized emulsions containing highly unsaturated oils
CA2016363A1 (fr) * 1989-06-05 1990-12-05 Kazuho Matsuura Methode de production de trehalose
US5242792A (en) * 1991-02-25 1993-09-07 The United States Of America As Represented By The Secretary Of The Navy Method for the preservation of red blood cells by lyophilization using glycerol or inositol with disaccharides
AU2309692A (en) * 1991-07-03 1993-02-11 Cryolife, Inc. Method for stabilization of biomaterials
JP3193423B2 (ja) * 1991-10-30 2001-07-30 株式会社資生堂 固型粉末化粧料
JP2933774B2 (ja) * 1991-12-19 1999-08-16 七郎 庭野 葉類加工食品及びその製法
FI943133A0 (fi) * 1994-06-29 1994-06-29 Alko Ab Oy Transgena vaexter
JPH05292986A (ja) * 1992-02-21 1993-11-09 Takeda Chem Ind Ltd トレハロースの製造法
JP3172925B2 (ja) * 1992-02-25 2001-06-04 株式会社林原生物化学研究所 ネオトレハロースの製造方法とその用途
CN1078117A (zh) * 1992-05-05 1993-11-10 地方国营海口市饼干厂 天然红萝卜露饮料的生产方法
DE69326101T2 (de) * 1992-06-02 2000-04-20 Ajinomoto Kk Verfahren zur Herstellung eines geformten gebundenen Nahrungsmittels
JP3168550B2 (ja) * 1992-12-02 2001-05-21 株式会社林原生物化学研究所 脱水剤およびそれを用いる含水物の脱水方法並びにその方法で得られる脱水物品
DK0691344T3 (da) 1992-12-28 2003-07-14 Hayashibara Biochem Lab Oprensning af trehalose
JP3201038B2 (ja) * 1993-01-28 2001-08-20 味の素株式会社 切花及び葉菜の鮮度保持剤
CN1091262A (zh) * 1993-02-26 1994-08-31 路明霞 健美菜果茶
IL108965A (en) * 1993-03-16 1998-07-15 Hayashibara Biochem Lab A complementary saccharine source - energy
CN1079880A (zh) * 1993-04-07 1993-12-29 沈玉水 天然延寿防癌保健茶
CN1094923A (zh) * 1993-05-08 1994-11-16 房玉斗 一种抗癌饮料的加工方法
JPH06319503A (ja) * 1993-05-17 1994-11-22 Asahi Chem Ind Co Ltd 新規凍結乾燥食品
JP3559585B2 (ja) * 1993-06-03 2004-09-02 株式会社林原生物化学研究所 トレハロース遊離酵素とその製造方法並びに用途
JPH0751063A (ja) * 1993-06-11 1995-02-28 Kirin Brewery Co Ltd 逆反応性を有するトレハラーゼ、およびα，α−トレハロースの製造方法
SK166095A3 (en) * 1993-06-30 1997-01-08 Mogen Int Production of trehalose in plants
WO1995006126A1 (fr) * 1993-08-24 1995-03-02 Mogen International N.V. Production de trehalose dans des vegetaux
JP3633648B2 (ja) 1993-07-20 2005-03-30 株式会社林原生物化学研究所 マルトース・トレハロース変換酵素とその製造方法並びに用途
JP3224647B2 (ja) * 1993-09-10 2001-11-05 三栄源エフ・エフ・アイ株式会社 加工食品の品質保存法
JPH07194378A (ja) * 1993-12-28 1995-08-01 Fuji Seito Kk トレハロースによる酵素の安定化法
CN1107716A (zh) * 1994-03-01 1995-09-06 吴夫增 一种能预防和治疗癌症的药剂
JPH0822237B2 (ja) 1994-03-08 1996-03-06 通商産業省基礎産業局長 トレハロースの製造方法
JP3532244B2 (ja) * 1994-05-20 2004-05-31 株式会社ナリス化粧品 ムコ多糖類断片化抑制剤、活性酸素消去剤および化粧料
US5567424A (en) * 1994-06-10 1996-10-22 Reliv International, Inc. Fiber, antioxidant, herbal and enzyme supplemented beverage composition for human consumption
IL114030A (en) * 1994-06-27 2000-08-13 Hayashibara Biochem Lab Saccharide composition with a lesser reducibility its preparation and compositions containing it
EP0693558B1 (fr) * 1994-07-19 2002-12-04 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Tréhalose, sa production et son utilisation
US5512547A (en) * 1994-10-13 1996-04-30 Wisconsin Alumni Research Foundation Pharmaceutical composition of botulinum neurotoxin and method of preparation
JPH08143466A (ja) * 1994-11-15 1996-06-04 Sanki Shoji Kk 天然抗酸化剤および活性酸素消去剤
JPH08140595A (ja) * 1994-11-24 1996-06-04 Pola Chem Ind Inc 食品添加剤
CN1040499C (zh) * 1994-11-25 1998-11-04 孙淑芝 胡萝卜土豆营养乳及制造方法
IL116564A0 (en) * 1995-01-04 1996-03-31 Mogen Int Process for producing trehalose in plants
DE19503685C2 (de) * 1995-01-30 2000-05-31 Invitek Gmbh Verfahren zur Herstellung komplexer multienzymatischer lagerstabiler Reaktionsgemische und deren Verwendung
US5556771A (en) * 1995-02-10 1996-09-17 Gen-Probe Incorporated Stabilized compositions of reverse transcriptase and RNA polymerase for nucleic acid amplification
JPH08228736A (ja) * 1995-02-27 1996-09-10 Arai Toshiharu 野菜水の製造方法およびその野菜水
JP3084609B2 (ja) * 1995-04-12 2000-09-04 株式会社林原生物化学研究所 トレハロース含有シラップ
JP3486266B2 (ja) * 1995-08-17 2004-01-13 日本食品化工株式会社 食品類の水分調節方法
US6551794B1 (en) * 1995-11-09 2003-04-22 E. R. Squibb & Sons, Inc. Stable biotinylated biomolecule composition
JPH09163943A (ja) * 1995-12-15 1997-06-24 Ajinomoto Co Inc チルド流通向け米飯食品
EP0784095A3 (fr) * 1996-01-12 1997-12-29 Mogen International N.V. L'accumulation de tréhalose améliorée dans des plantes
FR2747044B1 (fr) * 1996-04-03 1998-06-26 Coletica Utilisation de graines de vegetaux apres germination comme source de superoxyde dismutase et compositions cosmetiques, pharmaceutiques ou agroalimentaires contenant une telle superoxyde dismutase vegetale, et procede d'extraction
JPH09275994A (ja) * 1996-04-16 1997-10-28 Fuji Seito Kk トレハロースの製造法
MX205414B (es) * 1996-05-08 2001-12-07 Univ Mexico Nacional Autonoma Metodo para incrementar de trehalosa de los organismos por medio de su transformacion con el adnc de la trehalosa-6-fosfato sintasa/fosfatasa de selaginella lepidophylla.
PT101887A (pt) * 1996-06-28 1998-01-30 Inst De Biolog Ex E Tecnologic Utilizacao de 2-0- -manosilglicerato para termoestabilizacao, osmoproteccao e proteccao contra a desidratacao de enzimas, outros componenetes celulares e celulas
US5916881A (en) * 1996-10-07 1999-06-29 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo High trehalose content syrup
TW466116B (en) 1997-03-04 2001-12-01 Hayashibara Biochem Lab Reduction inhibitory agent for active-oxygen eliminating activity, method for inhibiting the reduction of said activity, and composition containing said agent
US5827886A (en) * 1997-05-07 1998-10-27 Thione International, Inc. Composition for relief of arthritis-induced symptoms

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6989161B2 (en) 2000-06-12 2006-01-24 Access Business Group International Llc Phytonutrient nutritional supplement
US20040223942A1 (en) * 2003-03-06 2004-11-11 Kao Corporation Skin aging-preventing or improving agent
EP1454620A3 (fr) * 2003-03-06 2005-04-13 Kao Corporation Agent anti-vieillissement ou améliorant de la peau
US20100273195A1 (en) * 2003-03-06 2010-10-28 Kao Corporation Skin aging-preventing or improving agent
US20050053555A1 (en) * 2003-07-14 2005-03-10 Crave Busters, Llc. Appetite control compositions and methods of use
US20080069910A1 (en) * 2005-02-03 2008-03-20 Tsutomu Okubo Preventive, Relieving or Therapeutic Composition for Diabetes Mellitus and/or Diabetic Nephropathy
US8029829B2 (en) 2005-02-03 2011-10-04 Taiyo Kagaku Co., Ltd. Preventive, relieving or therapeutic composition for diabetes mellitus and/or diabetic nephropathy

Also Published As

Publication number Publication date
US7186824B2 (en) 2007-03-06
EP0868916A3 (fr) 2004-09-15
EP0868916A2 (fr) 1998-10-07
TW466116B (en) 2001-12-01
US20040058592A1 (en) 2004-03-25
KR19980079895A (ko) 1998-11-25

Similar Documents

Publication Publication Date Title
US7186824B2 (en) Reduction inhibitory agent for active-oxygen eliminating activity
KR101095258B1 (ko) 조성물에 있어서의 수분의 변동을 억제하는 방법과 그 용도
KR100520724B1 (ko) 프로폴리스 추출물
KR101277180B1 (ko) 콜라겐 산생 증강제와 그 제조 방법 및 용도
EP1321148B1 (fr) Utilisation de cyclotetrasaccharides pour augmenter l'activité d'élimination de l'oxygène actif
US20060134197A1 (en) Method of reducing unpleasant taste and/or unpleasant odor
KR0156539B1 (ko) 4지-o-알파-디이-글루코피라노실 루틴 및 그 제조 방법
TWI361668B (fr)
US20070218189A1 (en) Reduction inhibitory agent for active oxygen eliminating-activity
EP2098240B1 (fr) Agent favorisant la guérison d'un organisme vivant
KR101075696B1 (ko) 휘발성 알데히드류의 생성 및/또는 지방산류의 분해를 억제하는 방법과 그 용도
JP4363841B2 (ja) ポリフェノールの水に対する溶解性の改善方法ならびにポリフェノール高含有水溶液
JPH11263795A (ja) 活性酸素消去能低減抑制剤
JP2010265215A (ja) メチオニナーゼ阻害剤
KR100967509B1 (ko) 결정 α-Ｄ-글루코실 α-Ｄ-갈락토시드와 이것을 함유하는당질 및 이들의 제조 방법 및 용도
KR20070113330A (ko) 곰피 추출물을 포함하는 피부외용제 조성물
JP4688474B2 (ja) 新規フラボノイド配糖体
KR102517664B1 (ko) 탈모 예방, 개선 또는 치료용 조성물 및 그의 제조방법
KR102012170B1 (ko) 바나나, 체리 및 호두의 혼합 추출물을 포함하는 피부 노화 방지 또는 개선용 조성물
RU2317299C2 (ru) Ассоциат, содержащий трегалозу и хлорид кальция, в форме кристаллического моногидрата или безводного кристалла
JP2004149454A (ja) クビレヅタに含まれる抗腫瘍活性成分を用いた製剤、化粧品、食品または食品添加物

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION